Nixi AI

AI documentation for rheumatology

Long initial histories, DAS28 follow-ups and biologic applications from the conversation. You review, Nixi AI writes the draft.

Fictional people, AI-generated.

Made for long
rheumatology consultations.

  1. 01 / 04

    Conversation

    From the first consultation to a structured history

    Nixi AI listens and sorts pain, medication and functional history into your structure. You review the draft before it goes into the record.

    Structured noteLive · 06:18
    Mrs Schneider · 58 · RA since 2018

    DAS28-CRP · follow-up

    History

    More stiffness over the last 4 weeks, 90 minutes in the morning, fatigue increased.

    Findings

    TJC 7 · SJC 4 · patient VAS 52/100 · CRP 14.2 mg/l. Tenderness MCP II–IV both sides, right wrist.

    DAS28 score · 4.71

    Moderate disease activity. Above treatment target (DAS28 < 3.2).

    Plan

    Continue MTX 15 mg sc once weekly · evaluate JAK inhibitor · review in 6 weeks with labs.

    Draft
  2. 02 / 04

    Letter

    Follow-up letter with scores, not clicks

    DAS28, CDAI, HAQ and the 28-joint status sit in the letter where they belong. Drafted from the conversation, released by you.

    Follow-up letterDraft
    Diagnosis

    Rheumatoid arthritis since 2018 (M06.90), currently moderate disease activity with DAS28-CRP 4.71.

    Course and findings

    More stiffness over the past 4 weeks, 90 minutes in the morning, increasing fatigue. TJC 7, SJC 4, patient VAS 52/100, CRP 14.2 mg/l. Tenderness of MCP II–IV on both sides and the right wrist.

    Plan

    Treatment target DAS28 < 3.2 not reached. Continue MTX 15 mg sc once weekly, JAK inhibitor under evaluation. Review in 6 weeks with bloods.

  3. 03 / 04

    Codes

    ICD-10-GM as suggestions for review

    Nixi AI suggests matching codes from the documentation. You confirm; billing stays with you.

    ICD-10-GM suggestions (selection)Suggestions to review
    • M06.90Rheumatoid arthritis, unspecified: multiple sitesRA since 2018 · MCP II–IV both sides, right wrist
  4. 04 / 04

    Practice system

    Into your record, by copy or interface

    The released text lands in Medistar, Turbomed, medatixx or your system. Copying on every plan, the direct interface in Practice Pro.

    Mrs Schneider · 58 · RA since 2018 · Practice system · record
    ANABEFTHEDIAGePALABREZÜBW
    28.04.26 DiANAMore stiffness over the last 4 weeks, 90 minutes in the morning, fatigue increased.
    28.04.26 DiBEFTJC 7 · SJC 4 · patient VAS 52/100 · CRP 14.2 mg/l. Tenderness MCP II–IV both sides, right wrist.
    28.04.26 DiDIAGM06.90
    28.04.26 DiTHEContinue MTX 15 mg sc once weekly · evaluate JAK inhibitor · review in 6 weeks with labs.
    CGM MedistarCGM TurbomedCGM M1 Promedatixx (x.isynet, x.concept)

Frequently asked

Your questions about Nixi AI in rheumatology.

  • Yes. Nixi AI was clinically evaluated in rheumatology: the EULAR 2025 study (Knitza & Aries, n=88 consultations) showed reduced documentation time in 82 % of consultations with zero major errors. Nixi AI drafts initial histories, follow-up letters and findings reports, and supports biologic applications. GDPR-compliant on GDPR-compliant cloud infrastructure.

Get to know Nixi AI through a rheumatology case.

Try it yourself, or let us show you in 30 minutes.

In German or English.